Nevertheless, glioblastoma tumor growth was reduced in CD73-null mice with combined inhibition of CTLA-4 and PD-1 checkpoints34 suggesting a potential benefit of combined inhibition of extracellular purinergic pathway and checkpoint pathways. The gene discussed is CTLA4; the disease is glioblastoma.